山本 祥之(ヤマモト ヨシユキ)
- 所属
- 医学医療系
- 職名
- 講師
- 職歴
2025-01 -- (現在) 筑波大学消化器内科講師 2014-04 -- 2024-12 筑波大学附属病院総合がん診療センター病院講師 2013-04 -- 2014-03 国立がん研究センター東病院臨床開発センター 新薬開発分野がん研究特別研究員 2011-04 -- 2013-03 国立がん研究センター東病院臨床開発センター 新薬開発分野リサーチレジデント 2009-04 -- 2011-03 筑波大学附属病院医員 2008-04 -- 2009-03 独立行政法人国立病院機構 水戸医療センター医員 2007-02 -- 2008-03 筑波大学附属病院医員 2006-10 -- 2007-01 茨城県立中央病院医員 2006-04 -- 2006-09 日製日立総合病院医員 2006-02 -- 2006-03 豊和麗病院初期研修医 さらに表示... - 学歴
2010-04 -- 2014-03 筑波大学大学院 人間総合科学研究科 疾患制御医学専攻 1998-04 -- 2004-03 高知大学 医学部 医学科 - 取得学位
2014-03 博士(医学) 筑波大学 - 論文
- A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322G
Wakabayashi Munehiro; Masuishi Toshiki; Ogata Takatsug...
Future oncology (London, England)/pp.1-7, 2025-06-06 - Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumors
Hashimoto Tadayoshi; Nakamura Yoshiaki; Komatsu Yoshit...
BJC reports/2(1)/p.54, 2024-07-25 - Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer: a multicenter retrospective cohort study
Hagiwara Yuya; Nakasya Akio; Matsumoto Toshihiko; Ikom...
Journal of gastrointestinal oncology/13(6)/pp.2769-2778, 2022-12-01 - Effect of combined treatment with micelle-incorporated cisplatin (NC-6004) and S-1 on human gastric cancer xenografts
Kudo Masahisa; Yamamoto Yoshiyuki; Koga Yoshikatsu; Ha...
Molecular and clinical oncology/5(6)/pp.817-822, 2016-12-01 - Antitumor effect of antitissue factor antibody-MMAE conjugate in human pancreatic tumor xenografts
Koga Yoshikatsu; Manabe Shino; Aihara Yoshiyuki; Sato ...
International journal of cancer/137(6)/pp.1457-1466, 2015-09-15 - The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution
Yasunaga Masahiro; Furuta Masaru; Ogata Koretsugu; Kog...
Scientific reports/3/p.3050, 2013-10-25 - Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test
Koga Yoshikatsu; Yamazaki Nobuyoshi; Yamamoto Yoshiyuk...
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology/22(10)/pp.1844-1852, 2013-10-01 - Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study)
Shoji Hirokazu; Kudo-Saito Chie; Nagashima Kengo; Imaz...
JOURNAL FOR IMMUNOTHERAPY OF CANCER/12(11), 2024-11-01 - Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study
Yamamoto Yoshiyuki; Yukami Hiroki; Yamaguchi Tatsuro; ...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/Epub, 2024-08-28 - Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer
Sudo Kentaro; Nakamura Yoshiaki; Ueno Makoto; Furukawa...
BRITISH JOURNAL OF CANCER/Epub, 2024-08-28 - Real-world treatment costs of first-line treatment for metastatic colorectal cancer: a survey of the JCOG colorectal cancer study group
Takashima Atsuo; Ishiguro Megumi; Sasaki Keita; Machid...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY/Epub, 2024-08-29 - QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC
Bando Hideaki; Kotani Daisuke; Satake Hironaga; Hamagu...
MED/5(9), 2024-09-13 - Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Hamano Jun; Higashibata Takahiro; Kessoku Takaomi; Kaj...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology/42(35)/p.JCO2400381, 2024-09-10 - A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G
Matsumoto Toshihiko; Yamamoto Yoshiyuki; Kotaka Masahi...
TARGETED ONCOLOGY/19(2)/pp.181-190, 2024-03 - Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer
Sunakawa Yu; Kuboki Yasutoshi; Watanabe Jun; Terazawa ...
TARGETED ONCOLOGY/19(1)/pp.59-69, 2024-01 - Sidedness-Dependent Prognostic Impact of Gene Alterations in Metastatic Colorectal Cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN)
Kajiwara Takeshi; Nishina Tomohiro; Yamashita Riu; Nak...
CANCERS/15(21), 2023-11 - Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)
Ando Koji; Nakamura Yoshiaki; Kitao Hiroyuki; Shimokaw...
BRITISH JOURNAL OF CANCER/129(6)/pp.1032-1039, 2023-10-05 - Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study
Mitani Seiichiro; Kito Yosuke; Hino Kaori; Kawakami K...
TARGETED ONCOLOGY/18(5)/pp.707-715, 2023-09 - Effect of massive ascites on ramucirumab pharmacokinetics in patients with gastrointestinal cancers: a population pharmacokinetic analysis
Kaneko Takuya; Doki Kosuke; Yamada Takeshi; Yamamoto ...
CANCER CHEMOTHERAPY AND PHARMACOLOGY/92(4)/pp.271-278, 2023-10 - Gastric neuroendocrine carcinoma presenting complete durable response by nivolumab treatment for multiple metastases and radiotherapy to oligoprogressive metastasis
Seyama Yusuke; Yamada Takeshi; Suzuki Hirosumi; Fukuda...
INTERNATIONAL CANCER CONFERENCE JOURNAL/12(4)/pp.268-273, 2023-10 - Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment
Fukuda Satoshi; Niisato Yusuke; Tsuji Miki; Fukuda So...
ANTICANCER RESEARCH/43(5)/pp.2085-2090, 2023-05 - Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II study protocol (TT-LAP trial)
Shimomura Osamu; Endo Masato; Makishima Hirokazu; Yama...
BMC CANCER/23(1)/p.624, 2023-07-04 - Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan
Aoki Masahiko; Kadowaki Shigenori; Takahashi Naoki; Su...
GASTRIC CANCER/26(1)/pp.132-144, 2023-01 - Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged > 75 years
Moriwaki Toshikazu; Nishina Tomohiro; Sakai Yoshinori; ...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY/52(7)/pp.717-726, 2022-07 - Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic Colorectal Cancer Receiving Standard-of-Care Chemotherapy
Mizukami Takuro; Takahashi Masaki; Sunakawa Yu; Yuki ...
TARGETED ONCOLOGY/17(3)/pp.343-353, 2022-05 - さらに表示...
- A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322G
- 会議発表等
- 進行再発胃癌に対するラムシルマブ併用化学療法の治療効果におよぼすプロトンポンプ阻害薬の影響
金子 卓也; 土岐 浩介; 山田 武史; 宇田 将人; 山本 祥之; 小林 真理子; 土屋 輝一郎; ...
第45回日本臨床薬理学会学術総会/2024-12-13--2024-12-14 - 大腸癌細胞株における Aurora kinase A 阻害薬 ・MEK 阻害薬併用の相乗効果及びその メカニズム
佐藤 雅志; 山本 祥之; 土屋 輝一郎
第111回日本消化器病学会総会/2025-4-24--2025-4-26 - 局所進行膵がんに対するトリプル(温熱+陽子線+GEM/Nab)術前治療
小田 竜也; 下村 治; 橋本 真治; 高橋 一広; 宮﨑 貴寛; 土井愛美; 中橋 宏充; 遠藤 ...
第125回日本外科学会定期学術集会/2025-4-10--2025-4-12 - 切除不能胃癌に対するConversion手術はどうするべきか:標準手術か拡大手術か
明石 義正; 小川 光一; 大和田 洋平; 山田 武史; 山本 祥之; 小田 竜也
第97回日本胃癌学会総会/2025-3-12--2025-3-14
- 進行再発胃癌に対するラムシルマブ併用化学療法の治療効果におよぼすプロトンポンプ阻害薬の影響
(最終更新日: 2025-06-08)